Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy

Eye

Volumn 18, Issue 10, 2004, Pages 990-995

  Stewart, W C ^a,b   Stewart, J A ^a,c   Day, D G ^c,d   Sharpe, E D ^e   Jenkins, J N ^a  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Atlanta Research Company   (United States)

^d Omni Eye Services   (United States)

^e Glaucoma Consultants and Center for Eye Research   (United States)

Author keywords

Brimonidine; Latanoprost; Latanoprost timolol

Indexed keywords

BRIMONIDINE; LATANOPROST; LATANOPROST PLUS TIMOLOL MALEATE; PLACEBO; TIMOLOL MALEATE;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CONJUNCTIVAL HYPEREMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRY EYE; EAR INFECTION; ERYTHEMA; EYE BURNING; EYE DISEASE; EYE IRRITATION; EYE PAIN; EYELID DISEASE; FATIGUE; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LACRIMATION; MALE; MUCUS; OCULAR PRURITUS; OPEN ANGLE GLAUCOMA; PRESSURE MEASUREMENT; PROSPECTIVE STUDY; PUNCTATE KERATITIS; RANDOMIZED CONTROLLED TRIAL; RETINA VEIN OCCLUSION; SIDE EFFECT; SINUSITIS; SKIN CYST; STATISTICAL ANALYSIS; TOOTH DISEASE; UVEITIS; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 7244229685     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701375     Document Type: Article

References (16)

1. Stewart WC, Stewart JA, Day D, Sharpe ED. Efficacy and safety of latanoprost/timolol maleate fixed combination versus timolol maleate and brimonidine given twice daily. Acta Ophthalmol Scand 2003; 81: 242-246.
2. Book SA Essentials of Statistics. McGraw Hill Book Company: New York, 1978, pp 117-122, 205-215.
3. Mundorf TK, Cate EA, Sine CS, Otero DW, Stewart JA, Stewart WC. The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily. J Ocular Pharm Therap 1998; 14: 129-135.
4. Duff GR. A double-masked crossover study comparing the effects of carteolol 1% and 2% on intraocular pressure. Acta Ophthalmol 1987; 65: 618-621.
5. Stewart WC, Sharpe ED, Harbin Jr TS, Pastor SA, Day DG, Holmes KT et al. Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce the intraocular pressure. Am J Ophthalmol 2000; 129: 723-727.
6. Stewart WC, Day DG, Sharpe ED, Dubiner HB, Holmes KT, Stewart JA. Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost. Am J Ophthalmol 1999; 128: 692-696.
7. Siegel S Nonparametric Statistics for the Behavioral Science. Series in Psychology. McGraw Hill Book Company,. New York, 1956, pp 63-67.
8. Pfeiffer N, and the German Latanoprost Fixed Combination study Group. A comparison of the fixed combination of latanoprost and timolol with IST individual components in patients with glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2000; 41 (suppl): S754.
9. Higginbotham EJ, Feldman R, Stiles M, Dubiner H, Fixed Combination Investigative Group. Latanoprost and timolol combination therapy versus monotherapy. Arch Ophthalmol 2002; 120: 915-922.
10. Stewart WC, Day DG, Stewart JA, Schuhr J, Latham KE. The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001; 131: 631-635.
11. Stewart WC, Holmes KT, Johnson MA. Washout periods for brimonidine 0.2% and latanoprost 0.005%. Am J Ophthalmol 2001; 131: 798-799.
12. Alm A, Stjernschantz J and the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol. Ophthalmology 1995; 102: 1743-1752.
13. Camras CB and the United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology 1996; 103: 138-147.
14. Watson P, Stjernschantz J, and the Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 1996; 103: 126-137.
15. Konstas AGP, Maltezos AC, Gandi S, Hudgins AC, Stewart WC. Comparison of the 24 hour intraocular pressure reduction with two dosing regimes of latanoprost and timolol in patients with open-angle glaucoma. Am J Ophthalmol 1999; 128: 15-20.
16. Konstas AGP, Nakos E, Tersis I, Lallos NA, Leech JN, Stewart WC. A comparison of once daily morning versus evening dosing of concomitant latanoprost/timolol. Am J Ophthalmol 2002; 133: 753-757.